Developments on drug delivery systems for the treatment of mycobacterial infections
The clinical management of tuberculosis and other mycobacterial diseases with antimycobacterial chemotherapy remains a difficult task. The classical treatment protocols are long-lasting; the drugs reach mycobacteria-infected macrophages in low amounts and/or do not persist long enough to develop the...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2008
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/1822/61464 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/61464 |